Biosimilar Filgrastim
Neutropenia
CommercialActive
Key Facts
About Biosidus
Argentina‑based biosimilar leader delivering affordable biologics to emerging markets.
View full company profileTherapeutic Areas
Other Neutropenia Drugs
| Drug | Company | Phase |
|---|---|---|
| Entolimod | Tivic | Pre-clinical/Phase 1 |
| Biosimilars (e.g., Sargramostim) | Phenotypeca | Commercial |